Vista Pharmaceuticals to Hold Board Meeting to Review Q2 Unaudited Financials and Limited Review Report
Vista Pharmaceuticals Ltd has scheduled a meeting of its Board of Directors to review the company's performance for the quarter ended June 30, 2026. The meeting is set to take place on Friday, August 14, 2026, at the company's Registered office.The primary agenda items for the Board include a thorough examination of the unaudited financial results for the quarter ending June 30, 2026. Additionally, the Board is scheduled to review the Limited Review Report corresponding to the same period.
The management has also indicated that any other business may be discussed with the permission of the Chair during the meeting.
AMAGI Stock Price Movement
As of 1:02 PM today, shares of Amagi Media Labs Limited are edging higher, trading at ₹653.25 after gaining ₹14.50 or 2.27% in live market activity. The stock trades on a volume of 116,651 shares as it extends its move from the previous close of ₹638.75.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.